,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Hair texture abnormal,3,17004621
1,22.1,Hair disorder,3,17004621
2,22.1,Madarosis,3,17004621
3,22.1,Alopecia,3,17004621
4,22.1,Hair colour changes,3,17004621
0,22.1,White blood cell count decreased,6,17004627
1,22.1,Neoplasm progression,6,17004627
2,22.1,Dyspepsia,6,17004627
3,22.1,Platelet count decreased,6,17004627
4,22.1,Anaemia,6,17004627
0,22.1,Small cell lung cancer,5,17004639
1,22.1,Gastric hypomotility,6,17004639
2,22.1,Nausea,3,17004639
3,22.1,Gastric hypomotility,3,17004639
4,22.1,Lung disorder,3,17004639
5,22.1,Ascites,6,17004639
6,22.1,Platelet count decreased,1,17004639
0,22.1,Haematocrit decreased,5,17004646
1,22.1,Haemoglobin decreased,5,17004646
2,22.1,Incorrect dose administered,5,17004646
3,22.1,Intestinal obstruction,5,17004646
4,22.1,Mean platelet volume decreased,5,17004646
5,22.1,Red blood cell count decreased,5,17004646
6,22.1,Death,5,17004646
7,22.1,Herpes zoster,5,17004646
8,22.1,Neoplasm progression,5,17004646
0,22.1,Cataract,6,17004652
0,22.1,Death,5,17004653
0,22.1,Death,5,17004654
0,22.1,Cystitis,1,17004656
0,22.1,Death,5,17004678
1,22.1,Haemorrhage,5,17004678
0,22.1,Dizziness,1,17004679
1,22.1,Dyspepsia,3,17004679
2,22.1,Dry mouth,1,17004679
3,22.1,Sepsis,1,17004679
4,22.1,Anaemia,1,17004679
0,22.1,Death,5,17004698
0,22.1,Skin exfoliation,3,17004742
1,22.1,Alopecia,3,17004742
2,22.1,Oral pain,3,17004742
3,22.1,Thermal burn,3,17004742
0,22.1,Oral pain,3,17004744
1,22.1,Vomiting,,17004744
2,22.1,Pain in extremity,3,17004744
3,22.1,Gastric ulcer,2,17004744
4,22.1,Glossodynia,3,17004744
5,22.1,Abdominal tenderness,3,17004744
0,22.1,Colitis,3,17004752
1,22.1,Fatigue,3,17004752
2,22.1,Lacrimation increased,3,17004752
3,22.1,Paraesthesia,3,17004752
4,22.1,Abdominal pain,3,17004752
5,22.1,Diarrhoea,3,17004752
6,22.1,Dyspnoea,3,17004752
7,22.1,Memory impairment,3,17004752
8,22.1,Pain,3,17004752
9,22.1,Rhinorrhoea,3,17004752
10,22.1,Arthralgia,3,17004752
11,22.1,Infection,3,17004752
12,22.1,Nausea,3,17004752
13,22.1,Oropharyngeal pain,3,17004752
0,22.1,Oral pain,3,17004753
1,22.1,Thermal burn,3,17004753
2,22.1,Alopecia,3,17004753
3,22.1,Skin exfoliation,3,17004753
0,22.1,Drug intolerance,6,17004754
0,22.1,Epistaxis,3,17004755
1,22.1,Hypoaesthesia,3,17004755
2,22.1,Stomatitis,3,17004755
3,22.1,Abdominal pain,3,17004755
4,22.1,Bone pain,3,17004755
5,22.1,Headache,3,17004755
6,22.1,Nasal crusting,3,17004755
7,22.1,Oedema peripheral,3,17004755
8,22.1,Incorrect drug administration rate,3,17004755
9,22.1,Periorbital oedema,3,17004755
10,22.1,Diarrhoea,3,17004755
11,22.1,Pain,3,17004755
12,22.1,Burning sensation,3,17004755
13,22.1,Clumsiness,3,17004755
14,22.1,Memory impairment,3,17004755
15,22.1,Paraesthesia,3,17004755
16,22.1,Nasal ulcer,3,17004755
17,22.1,Constipation,3,17004755
18,22.1,Chills,3,17004755
19,22.1,Infusion related reaction,3,17004755
20,22.1,Myalgia,3,17004755
0,22.1,Death,5,17004759
0,22.1,Toxicity to various agents,6,17004763
0,22.1,Ear pruritus,1,17004764
1,22.1,Throat irritation,1,17004764
0,22.1,Stomatitis,6,17004778
1,22.1,Thrombocytopenia,6,17004778
2,22.1,Cytopenia,6,17004778
0,22.1,Injection site erythema,3,17004779
1,22.1,Injection site pain,3,17004779
2,22.1,Injection site scar,1,17004779
3,22.1,Injection site abscess,3,17004779
4,22.1,Injection site abscess,1,17004779
5,22.1,Injection site necrosis,3,17004779
6,22.1,Injection site erythema,1,17004779
7,22.1,Injection site necrosis,1,17004779
8,22.1,Injection site pain,1,17004779
9,22.1,Injection site induration,1,17004779
10,22.1,Injection site swelling,3,17004779
11,22.1,Injection site induration,3,17004779
0,22.1,Arterial injury,6,17004786
1,22.1,Off label use,6,17004786
2,22.1,Chronic myeloid leukaemia,2,17004786
3,22.1,Cerebral infarction,4,17004786
4,22.1,Abdominal wall haematoma,2,17004786
5,22.1,Monoplegia,3,17004786
0,22.1,Arthralgia,2,17004808
1,22.1,Rash papular,1,17004808
0,22.1,Cystitis radiation,6,17004810
1,22.1,Urinary incontinence,6,17004810
2,22.1,Nephrolithiasis,6,17004810
3,22.1,Prostatectomy,6,17004810
4,22.1,Radiation associated haemorrhage,3,17004810
5,22.1,Internal haemorrhage,6,17004810
6,22.1,Urine output increased,6,17004810
7,22.1,Medical device pain,6,17004810
8,22.1,Hyperhidrosis,6,17004810
9,22.1,Prostatic specific antigen increased,6,17004810
10,22.1,Hot flush,6,17004810
11,22.1,Feeling of body temperature change,6,17004810
12,22.1,Insomnia,6,17004810
0,22.1,Metastases to bone,6,17004823
1,22.1,Drug resistance,6,17004823
0,22.1,Recalled product administered,6,17004825
1,22.1,Rectal cancer,6,17004825
0,22.1,Thrombocytopenia,1,17004829
0,22.1,Pulmonary tumour thrombotic microangiopathy,6,17004841
1,22.1,Pulmonary hypertension,6,17004841
0,22.1,Anxiety,3,17004845
1,22.1,Nervousness,3,17004845
2,22.1,Rhinorrhoea,3,17004845
3,22.1,Hypoaesthesia,3,17004845
4,22.1,Influenza like illness,3,17004845
5,22.1,Constipation,3,17004845
6,22.1,Dizziness,3,17004845
7,22.1,Epistaxis,3,17004845
8,22.1,Neuropathy peripheral,3,17004845
9,22.1,Cystitis,3,17004845
10,22.1,Nasopharyngitis,3,17004845
11,22.1,White blood cell count decreased,3,17004845
12,22.1,Nausea,3,17004845
13,22.1,Balance disorder,3,17004845
14,22.1,Dehydration,3,17004845
15,22.1,Diarrhoea,3,17004845
16,22.1,Ear infection,3,17004845
17,22.1,Rash,3,17004845
18,22.1,Vomiting,3,17004845
0,22.1,Left ventricular dysfunction,1,17004846
0,22.1,Death,5,17004864
0,22.1,Off label use,6,17004868
1,22.1,Uterine cancer,6,17004868
0,22.1,Oedema peripheral,3,17004873
1,22.1,Neuropathy peripheral,3,17004873
0,22.1,Myalgia,1,17004883
1,22.1,Gait disturbance,1,17004883
0,22.1,Malignant neoplasm progression,5,17004897
1,22.1,Encephalitis autoimmune,5,17004897
0,22.1,Tumour lysis syndrome,5,17004920
0,22.1,Rash,1,17004936
1,22.1,Neutropenia,2,17004936
0,22.1,Congestive cardiomyopathy,2,17004954
1,22.1,Toxicity to various agents,2,17004954
0,22.1,Hepatic failure,1,17004979
0,22.1,Haemophagocytic lymphohistiocytosis,1,17004980
0,22.1,Colorectal cancer,3,17004988
0,22.1,Off label use,,17004991
1,22.1,Colorectal cancer,3,17004991
0,22.1,Neoplasm progression,6,17004994
1,22.1,Disturbance in attention,6,17004994
2,22.1,Meningitis,6,17004994
3,22.1,Pyrexia,6,17004994
4,22.1,Madarosis,6,17004994
5,22.1,Weight decreased,1,17004994
6,22.1,Neutrophil count decreased,1,17004994
7,22.1,Fatigue,6,17004994
8,22.1,Urinary tract infection,6,17004994
9,22.1,Product dose omission,6,17004994
0,22.1,Metastases to lung,5,17005050
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,,17005050
2,22.1,Metastases to peritoneum,5,17005050
3,22.1,Ascites,,17005050
4,22.1,Metastases to central nervous system,5,17005050
5,22.1,Colorectal cancer,,17005050
6,22.1,Platelet count decreased,,17005050
0,22.1,Colorectal cancer,3,17005051
0,22.1,Death,5,17005079
1,22.1,Gastric ulcer perforation,6,17005079
0,22.1,Pancytopenia,2,17005141
0,22.1,Eosinophilia,2,17005191
1,22.1,Rash erythematous,2,17005191
0,22.1,Metastasis,6,17005242
1,22.1,Malignant neoplasm progression,6,17005242
0,22.1,Myocardial infarction,5,17005243
1,22.1,Diarrhoea,1,17005243
0,22.1,Myocardial infarction,6,17005248
0,22.1,Death,5,17005259
0,22.1,Death,5,17005260
0,22.1,Death,5,17005262
0,22.1,Death,5,17005299
0,22.1,Swelling face,1,17005302
1,22.1,Lip oedema,1,17005302
2,22.1,Eye swelling,1,17005302
0,22.1,Somnolence,6,17005323
1,22.1,White blood cell count decreased,6,17005323
2,22.1,Recurrent cancer,6,17005323
3,22.1,General physical health deterioration,6,17005323
4,22.1,Blindness,6,17005323
5,22.1,Neutrophil count decreased,6,17005323
6,22.1,Weight decreased,6,17005323
7,22.1,Metastases to spine,6,17005323
8,22.1,Eye infection bacterial,2,17005323
0,22.1,Thrombocytopenia,2,17005359
1,22.1,Creatinine renal clearance abnormal,3,17005359
2,22.1,Full blood count abnormal,3,17005359
3,22.1,Anaemia,3,17005359
4,22.1,White blood cell disorder,3,17005359
0,22.1,Radiation pneumonitis,1,17005360
1,22.1,Rash,6,17005360
0,22.1,Radiation pneumonitis,6,17005361
1,22.1,Lung consolidation,6,17005361
2,22.1,Pleural effusion,6,17005361
3,22.1,Metastases to bone,6,17005361
4,22.1,Malignant neoplasm progression,6,17005361
5,22.1,Lymphadenopathy,6,17005361
6,22.1,Pericardial effusion,6,17005361
7,22.1,Lymphangiosis carcinomatosa,6,17005361
8,22.1,Atelectasis,6,17005361
9,22.1,Pneumonia,6,17005361
10,22.1,Immune-mediated pneumonitis,6,17005361
0,22.1,Ileus,1,17005363
1,22.1,Incisional hernia,1,17005363
0,22.1,Diarrhoea,1,17005365
1,22.1,Malignant neoplasm progression,6,17005365
0,22.1,Thrombocytopenia,1,17005425
1,22.1,Anaemia,1,17005425
2,22.1,Neutropenia,1,17005425
0,22.1,Infection,1,17005440
0,22.1,Confusional state,5,17005446
1,22.1,Chronic obstructive pulmonary disease,5,17005446
2,22.1,Asthenia,5,17005446
0,22.1,Laboratory test abnormal,6,17005447
0,22.1,Leukopenia,1,17005449
1,22.1,Gastric ulcer perforation,5,17005449
0,22.1,Cataract,6,17005461
0,22.1,Lung neoplasm malignant,5,17005468
0,22.1,White blood cell count decreased,2,17005511
1,22.1,Diarrhoea,6,17005511
2,22.1,Granulocyte count decreased,6,17005511
3,22.1,Tracheitis,1,17005511
4,22.1,Disease progression,6,17005511
5,22.1,Red blood cell count decreased,6,17005511
6,22.1,Lower limb fracture,6,17005511
7,22.1,Mood altered,6,17005511
8,22.1,Memory impairment,6,17005511
9,22.1,Brain injury,6,17005511
10,22.1,Asthenia,6,17005511
11,22.1,Protein urine present,2,17005511
12,22.1,Abdominal pain,6,17005511
13,22.1,Fall,6,17005511
14,22.1,Bone marrow failure,6,17005511
15,22.1,Nasopharyngitis,6,17005511
16,22.1,White blood cell count decreased,6,17005511
17,22.1,Gastrointestinal disorder,6,17005511
18,22.1,Gastrointestinal pain,6,17005511
19,22.1,Gastrointestinal inflammation,6,17005511
20,22.1,Transaminases increased,1,17005511
21,22.1,Discomfort,6,17005511
22,22.1,White blood cell count decreased,3,17005511
23,22.1,Platelet count decreased,6,17005511
24,22.1,Decreased appetite,6,17005511
25,22.1,Abdominal pain,6,17005511
26,22.1,Poor quality sleep,6,17005511
27,22.1,Hypertension,1,17005511
28,22.1,Pyrexia,6,17005511
29,22.1,Gastroenteritis radiation,6,17005511
30,22.1,Protein urine present,6,17005511
0,22.1,Pneumothorax,3,17005576
1,22.1,Pneumonitis,3,17005576
2,22.1,Bronchial fistula,1,17005576
0,22.1,Fatigue,3,17005594
1,22.1,Weight decreased,6,17005594
2,22.1,Dizziness,2,17005594
3,22.1,Platelet count decreased,6,17005594
4,22.1,Ageusia,6,17005594
5,22.1,Bowel movement irregularity,6,17005594
6,22.1,Delusion,6,17005594
7,22.1,Constipation,6,17005594
8,22.1,Taste disorder,6,17005594
9,22.1,Insomnia,6,17005594
10,22.1,Hallucination,6,17005594
11,22.1,Nightmare,6,17005594
12,22.1,Product use in unapproved indication,6,17005594
13,22.1,Decreased appetite,6,17005594
0,22.1,Non-small cell lung cancer,5,17005609
1,22.1,Metastases to pleura,6,17005609
2,22.1,Ovarian cancer,5,17005609
3,22.1,Metastases to peritoneum,6,17005609
4,22.1,Malignant neoplasm progression,6,17005609
5,22.1,Cardiac failure,3,17005609
6,22.1,Intestinal obstruction,6,17005609
0,22.1,Death,5,17005627
0,22.1,Off label use,6,17005630
1,22.1,Metastases to lung,6,17005630
0,22.1,Neutrophil count decreased,6,17005634
0,22.1,Pneumonia,5,17005636
0,22.1,Skin burning sensation,3,17005660
1,22.1,Injection site abscess,3,17005660
2,22.1,Vein discolouration,3,17005660
0,22.1,Altered state of consciousness,5,17005668
1,22.1,Thrombocytopenia,6,17005668
2,22.1,Posterior reversible encephalopathy syndrome,6,17005668
0,22.1,Dementia Alzheimer^s type,3,17005670
1,22.1,Malignant neoplasm progression,6,17005670
0,22.1,Cerebral haemorrhage,5,17005672
1,22.1,Febrile neutropenia,5,17005672
2,22.1,Rhabdomyolysis,5,17005672
3,22.1,Pneumonia bacterial,6,17005672
0,22.1,Duodenal perforation,6,17005675
0,22.1,Pleural effusion,6,17005707
0,22.1,Abdominal pain,1,17005741
0,22.1,Neurotoxicity,6,17005774
1,22.1,Dermatitis acneiform,6,17005774
0,22.1,Autonomic neuropathy,3,17005793
1,22.1,Condition aggravated,3,17005793
2,22.1,Dehydration,3,17005793
3,22.1,Hypotension,3,17005793
4,22.1,Weight decreased,3,17005793
5,22.1,Arthralgia,3,17005793
6,22.1,Blood pressure fluctuation,3,17005793
7,22.1,Confusional state,3,17005793
8,22.1,Diarrhoea,3,17005793
9,22.1,Hypertension,3,17005793
10,22.1,Neuropathy peripheral,3,17005793
11,22.1,Cognitive disorder,3,17005793
12,22.1,Heart rate increased,3,17005793
13,22.1,Onychomadesis,3,17005793
14,22.1,Tachycardia,3,17005793
15,22.1,Taste disorder,3,17005793
16,22.1,Constipation,3,17005793
17,22.1,Depression,3,17005793
18,22.1,Fall,3,17005793
19,22.1,Fatigue,3,17005793
20,22.1,Nerve injury,3,17005793
21,22.1,Pruritus,3,17005793
22,22.1,Stress,3,17005793
23,22.1,Alopecia,3,17005793
24,22.1,Catatonia,3,17005793
25,22.1,Dizziness,3,17005793
26,22.1,Drug intolerance,3,17005793
27,22.1,Feeding disorder,3,17005793
28,22.1,Orthostatic hypotension,3,17005793
29,22.1,Slow speech,3,17005793
30,22.1,Tinnitus,3,17005793
31,22.1,Drug eruption,3,17005793
32,22.1,Headache,3,17005793
33,22.1,Malnutrition,3,17005793
34,22.1,Onychoclasis,3,17005793
35,22.1,Tremor,3,17005793
36,22.1,Vagus nerve disorder,3,17005793
37,22.1,Asthenia,3,17005793
38,22.1,Bone pain,3,17005793
39,22.1,Cardiac disorder,3,17005793
40,22.1,Chest discomfort,3,17005793
41,22.1,Dyspnoea,3,17005793
42,22.1,Feeling abnormal,3,17005793
43,22.1,Gait disturbance,3,17005793
44,22.1,Impaired gastric emptying,3,17005793
45,22.1,Rash,3,17005793
46,22.1,Vomiting,3,17005793
47,22.1,Concussion,3,17005793
48,22.1,Extrapyramidal disorder,3,17005793
49,22.1,Malabsorption,3,17005793
50,22.1,Nail infection,3,17005793
51,22.1,Nausea,3,17005793
52,22.1,Pain,3,17005793
53,22.1,Weight increased,3,17005793
0,22.1,Transfusion,,17005811
0,22.1,Pulmonary embolism,5,17005812
1,22.1,Tumour embolism,5,17005812
0,22.1,Hospitalisation,,17005844
0,22.1,Pancreatic carcinoma,6,17005866
1,22.1,Second primary malignancy,6,17005866
2,22.1,Nausea,1,17005866
0,22.1,Carbohydrate antigen 15-3 increased,6,17005873
1,22.1,White blood cell count decreased,6,17005873
2,22.1,Neutropenia,6,17005873
0,22.1,Peritonitis,3,17005885
0,22.1,Back pain,6,17005886
1,22.1,Arthritis,6,17005886
2,22.1,Taste disorder,6,17005886
3,22.1,Muscle tightness,6,17005886
4,22.1,Diarrhoea,3,17005886
5,22.1,Dyspnoea,3,17005886
6,22.1,Arthralgia,6,17005886
7,22.1,Gallbladder disorder,6,17005886
8,22.1,Blood pressure increased,3,17005886
9,22.1,Postmenopausal haemorrhage,6,17005886
10,22.1,Hallucination,3,17005886
11,22.1,Lip swelling,3,17005886
12,22.1,Gastritis,6,17005886
13,22.1,Decreased appetite,6,17005886
14,22.1,Food craving,6,17005886
15,22.1,Peripheral swelling,2,17005886
16,22.1,Skin irritation,2,17005886
17,22.1,Dry mouth,6,17005886
18,22.1,Chest pain,3,17005886
19,22.1,Stomatitis,3,17005886
20,22.1,Blister,2,17005886
21,22.1,Lip dry,6,17005886
22,22.1,Dehydration,6,17005886
23,22.1,Abdominal pain upper,3,17005886
24,22.1,Blood pressure fluctuation,3,17005886
25,22.1,Myalgia,6,17005886
26,22.1,Gait disturbance,2,17005886
27,22.1,Insomnia,6,17005886
28,22.1,Ligament rupture,3,17005886
29,22.1,Irritable bowel syndrome,6,17005886
30,22.1,Depression,6,17005886
31,22.1,Diabetes mellitus,6,17005886
32,22.1,Pain,6,17005886
33,22.1,Hyperkeratosis,6,17005886
34,22.1,Rash,6,17005886
0,22.1,Death,5,17005888
0,22.1,Hepatic function abnormal,6,17005899
0,22.1,Hyponatraemia,3,17005943
0,22.1,Emotional distress,6,17005958
1,22.1,Impaired quality of life,6,17005958
2,22.1,Alopecia,2,17005958
3,22.1,Anxiety,6,17005958
4,22.1,Pain,6,17005958
0,22.1,Alopecia,3,17005994
1,22.1,Pain,6,17005994
2,22.1,Emotional distress,6,17005994
3,22.1,Anxiety,6,17005994
4,22.1,Impaired quality of life,6,17005994
0,22.1,Death,,17005995
0,22.1,Psychological trauma,6,17005996
1,22.1,Anxiety,6,17005996
2,22.1,Impaired quality of life,6,17005996
3,22.1,Alopecia,2,17005996
4,22.1,Pain,6,17005996
5,22.1,Emotional distress,6,17005996
0,22.1,Impaired quality of life,6,17006001
1,22.1,Pain,6,17006001
2,22.1,Anxiety,6,17006001
3,22.1,Alopecia,2,17006001
4,22.1,Emotional distress,6,17006001
0,22.1,Alopecia,2,17006004
1,22.1,Anxiety,6,17006004
2,22.1,Psychological trauma,6,17006004
3,22.1,Emotional distress,6,17006004
4,22.1,Impaired quality of life,6,17006004
5,22.1,Pain,6,17006004
0,22.1,Psychological trauma,6,17006007
1,22.1,Anxiety,6,17006007
2,22.1,Emotional distress,6,17006007
3,22.1,Impaired quality of life,6,17006007
4,22.1,Alopecia,2,17006007
5,22.1,Pain,6,17006007
0,22.1,Alopecia,3,17006008
1,22.1,Impaired quality of life,6,17006008
2,22.1,Anxiety,6,17006008
0,22.1,Impaired quality of life,6,17006016
1,22.1,Anxiety,6,17006016
2,22.1,Psychological trauma,6,17006016
3,22.1,Alopecia,2,17006016
4,22.1,Emotional distress,6,17006016
5,22.1,Pain,6,17006016
0,22.1,Emotional distress,6,17006019
1,22.1,Impaired quality of life,6,17006019
2,22.1,Alopecia,2,17006019
3,22.1,Pain,6,17006019
4,22.1,Anxiety,6,17006019
0,22.1,Pain,6,17006029
1,22.1,Alopecia,2,17006029
2,22.1,Impaired quality of life,6,17006029
3,22.1,Anxiety,6,17006029
4,22.1,Psychological trauma,6,17006029
5,22.1,Emotional distress,6,17006029
0,22.1,Pain,6,17006030
1,22.1,Impaired quality of life,6,17006030
2,22.1,Alopecia,2,17006030
3,22.1,Anxiety,6,17006030
4,22.1,Psychological trauma,6,17006030
5,22.1,Emotional distress,6,17006030
0,22.1,Anxiety,6,17006035
1,22.1,Pain,6,17006035
2,22.1,Alopecia,2,17006035
3,22.1,Emotional distress,6,17006035
4,22.1,Impaired quality of life,6,17006035
5,22.1,Psychological trauma,6,17006035
0,22.1,Alopecia,2,17006039
1,22.1,Psychological trauma,6,17006039
0,22.1,Anxiety,6,17006043
1,22.1,Impaired quality of life,6,17006043
2,22.1,Psychological trauma,6,17006043
3,22.1,Pain,6,17006043
4,22.1,Alopecia,2,17006043
5,22.1,Emotional distress,6,17006043
0,22.1,Alopecia,2,17006044
1,22.1,Emotional distress,6,17006044
2,22.1,Impaired quality of life,6,17006044
3,22.1,Psychological trauma,6,17006044
4,22.1,Pain,6,17006044
5,22.1,Anxiety,6,17006044
0,22.1,Alopecia,2,17006055
1,22.1,Pain,6,17006055
2,22.1,Impaired quality of life,6,17006055
3,22.1,Anxiety,6,17006055
4,22.1,Emotional distress,6,17006055
0,22.1,Alopecia,2,17006061
0,22.1,Impaired quality of life,6,17006062
1,22.1,Anxiety,6,17006062
2,22.1,Emotional distress,6,17006062
3,22.1,Pain,6,17006062
4,22.1,Psychological trauma,6,17006062
5,22.1,Alopecia,2,17006062
0,22.1,Alopecia,2,17006078
1,22.1,Psychological trauma,6,17006078
0,22.1,Alopecia,2,17006079
0,22.1,Psychological trauma,6,17006081
1,22.1,Alopecia,2,17006081
0,22.1,Metastases to bone,6,17006156
1,22.1,Non-small cell lung cancer,6,17006156
2,22.1,Malignant neoplasm progression,6,17006156
0,22.1,General physical health deterioration,3,17006165
1,22.1,Flushing,2,17006165
2,22.1,Diarrhoea,2,17006165
3,22.1,Intestinal perforation,2,17006165
4,22.1,Abdominal pain,2,17006165
5,22.1,Dry skin,3,17006165
6,22.1,Rash,2,17006165
0,22.1,Rash,6,17006187
0,22.1,Drug hypersensitivity,6,17006208
1,22.1,Rash,6,17006208
2,22.1,Pain,6,17006208
0,22.1,Vomiting,6,17006226
1,22.1,Nausea,6,17006226
2,22.1,Visual impairment,6,17006226
0,22.1,Death,,17006271
0,22.1,Pneumonia,6,17006315
0,22.1,Heart rate decreased,6,17006343
1,22.1,Electrocardiogram QT prolonged,4,17006343
0,22.1,Neuropathy peripheral,,17006357
0,22.1,Neutropenia,6,17006368
1,22.1,Thrombosis,2,17006368
0,22.1,Hot flush,3,17006391
1,22.1,Micturition urgency,3,17006391
2,22.1,Pain,3,17006391
0,22.1,Brain neoplasm malignant,3,17006393
0,22.1,Coagulation test abnormal,6,17006395
1,22.1,Malignant neoplasm progression,6,17006395
2,22.1,Oedema peripheral,1,17006395
0,22.1,Death,5,17006404
0,22.1,Product quality issue,,17006407
1,22.1,Intercepted medication error,,17006407
0,22.1,Intercepted product preparation error,,17006417
1,22.1,Syringe issue,,17006417
2,22.1,Product physical consistency issue,,17006417
3,22.1,Product colour issue,,17006417
0,22.1,Blood testosterone increased,6,17006422
1,22.1,Platelet count increased,6,17006422
2,22.1,Hepatic function abnormal,6,17006422
3,22.1,Prostatic specific antigen increased,6,17006422
4,22.1,Drug ineffective,,17006422
0,22.1,Transient ischaemic attack,1,17006423
0,22.1,Nephropathy toxic,1,17006438
1,22.1,Hepatobiliary disease,3,17006438
0,22.1,No adverse event,6,17006451
1,22.1,Product dose omission,6,17006451
2,22.1,Product availability issue,6,17006451
0,22.1,Haemophagocytic lymphohistiocytosis,6,17006482
1,22.1,White blood cell count decreased,6,17006482
2,22.1,Neutrophil count decreased,6,17006482
3,22.1,Eosinophil percentage increased,6,17006482
4,22.1,Platelet count decreased,6,17006482
0,22.1,Abdominal discomfort,,17006502
1,22.1,Hypersensitivity,,17006502
2,22.1,Feeling hot,,17006502
3,22.1,Flushing,,17006502
0,22.1,Anaemia,1,17006507
1,22.1,General physical health deterioration,6,17006507
2,22.1,Weight decreased,6,17006507
3,22.1,Diarrhoea,6,17006507
0,22.1,Cardiac arrest,2,17006523
0,22.1,Gastrointestinal anastomotic leak,6,17006544
1,22.1,Pain in extremity,6,17006544
2,22.1,Nausea,6,17006544
3,22.1,Anxiety,6,17006544
4,22.1,Hypertension,6,17006544
5,22.1,Neoplasm progression,6,17006544
0,22.1,Myelodysplastic syndrome,3,17006582
0,22.1,Oral discomfort,,17006605
0,22.1,Product use issue,6,17006648
1,22.1,Death,5,17006648
2,22.1,Product use in unapproved indication,6,17006648
0,22.1,Immune-mediated hypothyroidism,6,17006740
0,22.1,Embolism,6,17006822
1,22.1,Pulmonary haemorrhage,6,17006822
0,22.1,Asthenia,,17006833
0,22.1,Death,,17006840
0,22.1,Renal failure,,17006854
1,22.1,Dehydration,,17006854
2,22.1,Diarrhoea,,17006854
3,22.1,Nausea,,17006854
4,22.1,Vomiting,,17006854
0,22.1,Urticaria,3,17006899
1,22.1,Skin exfoliation,3,17006899
0,22.1,Flushing,2,17006941
1,22.1,Bronchospasm,1,17006941
0,22.1,Therapy cessation,,17006943
1,22.1,Acute respiratory failure,,17006943
0,22.1,Ascites,6,17006956
0,22.1,Death,5,17006967
0,22.1,Off label use,6,17006974
1,22.1,Ovarian cancer recurrent,6,17006974
0,22.1,Immune-mediated hypothyroidism,6,17006980
0,22.1,Bone pain,,17007057
1,22.1,Joint swelling,,17007057
2,22.1,Diarrhoea,,17007057
0,22.1,Hepatic function abnormal,2,17007099
0,22.1,Death,5,17007100
0,22.1,Nausea,1,17007113
1,22.1,Neutrophil count decreased,1,17007113
2,22.1,Pneumonia,1,17007113
3,22.1,Febrile infection,1,17007113
4,22.1,Depression,6,17007113
5,22.1,Leukopenia,1,17007113
6,22.1,C-reactive protein increased,1,17007113
7,22.1,Neutropenia,1,17007113
0,22.1,Bone marrow failure,1,17007242
0,22.1,Skin toxicity,6,17007263
1,22.1,Neuropathy peripheral,6,17007263
2,22.1,Adverse drug reaction,1,17007263
3,22.1,Disease progression,6,17007263
4,22.1,Dementia,6,17007263
0,22.1,Melaena,1,17007309
1,22.1,Gastrointestinal fistula,1,17007309
2,22.1,Dry skin,3,17007309
3,22.1,Soft tissue disorder,1,17007309
4,22.1,Hypokalaemia,1,17007309
5,22.1,Hypoalbuminaemia,1,17007309
6,22.1,Pyrexia,1,17007309
7,22.1,Blood folate decreased,3,17007309
8,22.1,Skin irritation,1,17007309
9,22.1,Neutrophil count decreased,1,17007309
10,22.1,Weight decreased,1,17007309
11,22.1,Weight increased,1,17007309
12,22.1,Weight increased,3,17007309
13,22.1,Protein total increased,1,17007309
14,22.1,Blood chloride increased,3,17007309
15,22.1,Lymphocyte count decreased,1,17007309
16,22.1,Aspartate aminotransferase increased,1,17007309
17,22.1,Anion gap decreased,3,17007309
18,22.1,Gastric haemorrhage,4,17007309
19,22.1,Hypothyroidism,3,17007309
20,22.1,White blood cell count decreased,1,17007309
21,22.1,Diarrhoea,1,17007309
22,22.1,Osteoarthritis,1,17007309
23,22.1,Hyperglycaemia,1,17007309
24,22.1,Neutrophil count decreased,1,17007309
25,22.1,Blood urea increased,1,17007309
26,22.1,Amylase increased,1,17007309
27,22.1,Oral pain,1,17007309
28,22.1,Aspartate aminotransferase increased,1,17007309
29,22.1,Blood creatinine decreased,1,17007309
30,22.1,Blood bilirubin increased,3,17007309
31,22.1,Blood creatinine decreased,1,17007309
32,22.1,Transferrin decreased,3,17007309
33,22.1,White blood cell count decreased,1,17007309
34,22.1,Lymphocyte count decreased,1,17007309
35,22.1,Lymphocyte count decreased,3,17007309
36,22.1,Productive cough,3,17007309
37,22.1,Dizziness,1,17007309
38,22.1,Hypertension,1,17007309
39,22.1,Haemoptysis,1,17007309
40,22.1,Neutrophil count increased,1,17007309
41,22.1,Hyperglycaemia,1,17007309
42,22.1,Concomitant disease aggravated,3,17007309
43,22.1,Aspartate aminotransferase increased,1,17007309
44,22.1,Oedema peripheral,1,17007309
45,22.1,Lymphocyte count decreased,1,17007309
46,22.1,Pain in extremity,1,17007309
47,22.1,Blood alkaline phosphatase increased,3,17007309
48,22.1,Hypoalbuminaemia,1,17007309
49,22.1,Gastrooesophageal reflux disease,1,17007309
50,22.1,Tachycardia,1,17007309
51,22.1,Aspartate aminotransferase increased,3,17007309
52,22.1,Hypokalaemia,1,17007309
53,22.1,Fatigue,3,17007309
54,22.1,Pruritus,1,17007309
55,22.1,Neutrophil count decreased,1,17007309
56,22.1,Hypertension,1,17007309
57,22.1,Anaemia,1,17007309
58,22.1,Oedema,1,17007309
59,22.1,Pain in extremity,1,17007309
60,22.1,Chills,1,17007309
61,22.1,Blood iron decreased,3,17007309
62,22.1,Protein total decreased,1,17007309
63,22.1,Hyperglycaemia,3,17007309
64,22.1,Rash,1,17007309
65,22.1,Gastric haemorrhage,1,17007309
66,22.1,Anaemia,4,17007309
67,22.1,White blood cell count increased,1,17007309
68,22.1,White blood cell count increased,1,17007309
69,22.1,Dyspnoea,1,17007309
70,22.1,Blood urea increased,3,17007309
71,22.1,Hyperglycaemia,1,17007309
72,22.1,Haemoptysis,2,17007309
73,22.1,Dizziness,1,17007309
74,22.1,Anaemia,3,17007309
75,22.1,Pain,1,17007309
76,22.1,Aspartate aminotransferase increased,1,17007309
77,22.1,Hypertension,1,17007309
78,22.1,Decreased appetite,3,17007309
79,22.1,Rash maculo-papular,3,17007309
80,22.1,Hypoalbuminaemia,1,17007309
81,22.1,Neutrophil count decreased,1,17007309
82,22.1,Lipase increased,1,17007309
83,22.1,Hypoalbuminaemia,3,17007309
84,22.1,Pruritus,3,17007309
85,22.1,Headache,1,17007309
86,22.1,Dysphonia,3,17007309
87,22.1,Hypertension,3,17007309
88,22.1,Hypocalcaemia,1,17007309
89,22.1,Thrombophlebitis superficial,6,17007309
90,22.1,Hypoalbuminaemia,1,17007309
91,22.1,Hyponatraemia,1,17007309
0,22.1,Balance disorder,1,17007342
1,22.1,Cerebral ischaemia,1,17007342
2,22.1,Nausea,1,17007342
3,22.1,Lacunar infarction,1,17007342
4,22.1,Visual impairment,1,17007342
5,22.1,Hypoaesthesia,1,17007342
0,22.1,Unresponsive to stimuli,6,17007345
1,22.1,Hypotension,6,17007345
2,22.1,Diarrhoea,6,17007345
3,22.1,Blood potassium decreased,6,17007345
4,22.1,Influenza like illness,6,17007345
5,22.1,White blood cell count abnormal,6,17007345
6,22.1,Dizziness,6,17007345
7,22.1,Vomiting,6,17007345
0,22.1,Blood magnesium decreased,3,17007346
1,22.1,Neutrophil count increased,3,17007346
2,22.1,Pneumonia,3,17007346
3,22.1,Protein total decreased,3,17007346
4,22.1,Wound,3,17007346
5,22.1,Platelet count decreased,3,17007346
6,22.1,Blood bilirubin increased,3,17007346
7,22.1,Oxygen saturation decreased,3,17007346
8,22.1,Respiration abnormal,3,17007346
9,22.1,Blood disorder,3,17007346
10,22.1,Hypotension,3,17007346
11,22.1,Infusion related reaction,3,17007346
12,22.1,Haematocrit decreased,3,17007346
13,22.1,Pleural effusion,3,17007346
14,22.1,Red blood cell count decreased,3,17007346
15,22.1,Red cell distribution width increased,3,17007346
16,22.1,Urinary tract infection,3,17007346
17,22.1,Weight decreased,3,17007346
18,22.1,Fatigue,3,17007346
19,22.1,Blood alkaline phosphatase increased,3,17007346
20,22.1,Blood calcium decreased,3,17007346
21,22.1,Blood creatinine decreased,3,17007346
22,22.1,Blood lactate dehydrogenase increased,3,17007346
23,22.1,Lymphocyte count decreased,3,17007346
24,22.1,Spinal fracture,3,17007346
0,22.1,Pneumonia,1,17007347
0,22.1,Micturition urgency,1,17007379
1,22.1,Blood pressure increased,1,17007379
2,22.1,Feeling hot,1,17007379
3,22.1,Chest pain,1,17007379
0,22.1,Rash,2,17007415
1,22.1,Tinnitus,1,17007415
2,22.1,Hypomagnesaemia,3,17007415
0,22.1,Hyperthermia,1,17007421
1,22.1,Chills,1,17007421
0,22.1,Death,5,17007467
0,22.1,Large intestinal haemorrhage,6,17007478
1,22.1,Thrombosis,6,17007478
2,22.1,Death,5,17007478
3,22.1,Intentional product use issue,6,17007478
4,22.1,Off label use,6,17007478
0,22.1,Pancytopenia,2,17007482
1,22.1,Anaemia,2,17007482
2,22.1,Oedema peripheral,2,17007482
0,22.1,Immune thrombocytopenic purpura,1,17007516
1,22.1,Hyperlipidaemia,6,17007516
2,22.1,Pulmonary mass,6,17007516
3,22.1,Bone marrow failure,6,17007516
4,22.1,Coronary artery disease,6,17007516
5,22.1,Lung consolidation,6,17007516
0,22.1,Metastases to central nervous system,6,17007531
0,22.1,Pneumonia,1,17007541
0,22.1,Pancytopenia,1,17007544
0,22.1,Drug ineffective,5,17007552
0,22.1,Cardiac disorder,3,17007609
1,22.1,Arrhythmia,3,17007609
0,22.1,Acute kidney injury,2,17007706
1,22.1,Condition aggravated,2,17007706
0,22.1,Diabetes mellitus,3,17007723
0,22.1,Pneumonitis,6,17007741
1,22.1,Colitis,6,17007741
0,22.1,Fatigue,1,17007776
1,22.1,Hip fracture,1,17007776
2,22.1,Abdominal discomfort,1,17007776
3,22.1,Memory impairment,1,17007776
4,22.1,Asthenia,3,17007776
0,22.1,Pneumonitis,6,17007801
0,22.1,Neuropathy peripheral,6,17007804
0,22.1,Pneumonitis,6,17007805
0,22.1,Pneumonitis,6,17007812
0,22.1,Pneumonitis,3,17007887
0,22.1,Post procedural complication,6,17007930
1,22.1,Gait disturbance,6,17007930
2,22.1,Muscle disorder,3,17007930
3,22.1,Muscular weakness,3,17007930
4,22.1,Gallbladder disorder,6,17007930
5,22.1,Prostatic disorder,6,17007930
6,22.1,Blood testosterone decreased,3,17007930
0,22.1,Rash maculo-papular,1,17007969
0,22.1,Neutropenia,2,17007977
0,22.1,Disseminated Bacillus Calmette-Guerin infection,6,17007992
0,22.1,Depression,6,17008013
1,22.1,Fatigue,6,17008013
2,22.1,Nausea,6,17008013
3,22.1,Pneumonia,6,17008013
4,22.1,Stomatitis,6,17008013
5,22.1,Thrombocytopenia,6,17008013
6,22.1,Acute kidney injury,6,17008013
7,22.1,Syncope,6,17008013
8,22.1,Tremor,6,17008013
9,22.1,Off label use,6,17008013
10,22.1,Decreased appetite,6,17008013
11,22.1,Anaemia,6,17008013
12,22.1,Urinary tract infection,6,17008013
13,22.1,Dizziness,6,17008013
14,22.1,Toxicity to various agents,6,17008013
15,22.1,Anxiety,6,17008013
0,22.1,Myalgia,1,17008019
1,22.1,Gait disturbance,1,17008019
0,22.1,Rash,3,17008054
0,22.1,Liver function test abnormal,6,17008062
1,22.1,Toxicity to various agents,6,17008062
2,22.1,Therapy partial responder,6,17008062
0,22.1,Death,5,17008082
0,22.1,Cough,3,17008103
1,22.1,Nausea,3,17008103
2,22.1,Drug interaction,3,17008103
3,22.1,Coagulopathy,3,17008103
4,22.1,Diarrhoea,3,17008103
5,22.1,Heart rate decreased,3,17008103
0,22.1,Cardiac dysfunction,3,17008107
1,22.1,Dyspnoea,2,17008107
2,22.1,Cardiac failure,2,17008107
0,22.1,Malignant neoplasm progression,6,17008122
0,22.1,Hypocalcaemia,1,17008199
1,22.1,Haematuria,3,17008199
2,22.1,Ischaemic stroke,3,17008199
3,22.1,Thrombocytopenia,3,17008199
0,22.1,Interstitial lung disease,1,17008234
1,22.1,Adrenocorticotropic hormone deficiency,1,17008234
0,22.1,Leukopenia,6,17008265
1,22.1,Nausea,6,17008265
2,22.1,Neutropenia,6,17008265
3,22.1,Anaemia,6,17008265
4,22.1,Asthenia,6,17008265
5,22.1,Neoplasm progression,6,17008265
0,22.1,Arrhythmia supraventricular,3,17008288
0,22.1,Pericardial effusion,1,17008325
0,22.1,Neutropenia,1,17008374
0,22.1,Febrile neutropenia,6,17008385
0,22.1,Asthenia,1,17008461
1,22.1,Neuropathy peripheral,2,17008461
2,22.1,Diarrhoea,1,17008461
3,22.1,Leukopenia,1,17008461
4,22.1,Neutropenia,1,17008461
5,22.1,Nausea,1,17008461
0,22.1,Chest discomfort,6,17008466
1,22.1,Hyperhidrosis,6,17008466
2,22.1,Flushing,6,17008466
0,22.1,Brain herniation,5,17008480
1,22.1,Foetal death,3,17008480
2,22.1,Exposure during pregnancy,6,17008480
3,22.1,Foetal growth restriction,3,17008480
0,22.1,Hypersensitivity,6,17008502
1,22.1,Lupus-like syndrome,6,17008502
2,22.1,Laboratory test abnormal,6,17008502
0,22.1,Pyrexia,6,17008511
1,22.1,Pain,6,17008511
2,22.1,Myalgia,6,17008511
3,22.1,Death,5,17008511
4,22.1,Peripheral swelling,6,17008511
0,22.1,Drug interaction,6,17008564
1,22.1,Depression,6,17008564
2,22.1,Product prescribing error,6,17008564
0,22.1,Death,5,17008605
0,22.1,Pneumonitis,6,17008625
0,22.1,Atrial fibrillation,6,17008631
1,22.1,Bundle branch block left,6,17008631
0,22.1,Pain,2,17008687
1,22.1,Orthopaedic procedure,6,17008687
2,22.1,Bone density decreased,6,17008687
3,22.1,Death,5,17008687
4,22.1,Post procedural complication,6,17008687
5,22.1,Prostate cancer,3,17008687
0,22.1,Jaundice,3,17008716
1,22.1,Disease progression,6,17008716
2,22.1,Ascites,6,17008716
3,22.1,Blood bilirubin increased,6,17008716
0,22.1,Bladder mass,1,17008728
0,22.1,Hypersensitivity,1,17008744
0,22.1,Failure to thrive,6,17008749
0,22.1,Rash papular,6,17008756
1,22.1,Rash erythematous,6,17008756
0,22.1,Death,5,17008849
0,22.1,Drug resistance,6,17008854
0,22.1,Ovarian cancer recurrent,6,17008925
1,22.1,Malignant neoplasm progression,3,17008925
0,22.1,Interstitial lung disease,2,17008926
1,22.1,Hypoxia,1,17008926
2,22.1,Malaise,1,17008926
3,22.1,Anaemia,1,17008926
4,22.1,Nausea,1,17008926
0,22.1,Streptococcus test,6,17009134
1,22.1,Acute hepatic failure,5,17009134
2,22.1,Acute kidney injury,6,17009134
0,22.1,Left ventricular dysfunction,2,17009163
0,22.1,Intentional product use issue,6,17009189
1,22.1,Pneumonitis,6,17009189
2,22.1,Respiratory failure,6,17009189
0,22.1,Malignant neoplasm progression,6,17009204
0,22.1,Balance disorder,2,17009213
1,22.1,Hypertension,2,17009213
0,22.1,Death,5,17009224
0,22.1,Myocarditis,6,17009247
1,22.1,Rebound effect,6,17009247
2,22.1,Drug ineffective,6,17009247
3,22.1,Abdominal discomfort,6,17009247
0,22.1,Hyperglycaemic hyperosmolar nonketotic syndrome,2,17009282
0,22.1,Pleural effusion,1,17009283
1,22.1,Drug resistance,6,17009283
2,22.1,Malignant neoplasm progression,6,17009283
0,22.1,Hepatotoxicity,6,17009285
1,22.1,Chronic hepatitis,6,17009285
0,22.1,Type 2 diabetes mellitus,3,17009325
1,22.1,Glycosylated haemoglobin increased,6,17009325
2,22.1,Diabetic ketoacidosis,6,17009325
3,22.1,Neutropenic sepsis,6,17009325
4,22.1,Atrial fibrillation,6,17009325
0,22.1,Oedema peripheral,1,17009339
1,22.1,Myalgia,1,17009339
0,22.1,Atrial fibrillation,4,17009392
1,22.1,Cardiac failure acute,4,17009392
2,22.1,Left ventricular dysfunction,4,17009392
0,22.1,Drug resistance,6,17009455
0,22.1,White blood cell count decreased,6,17009482
0,22.1,Hair disorder,3,17009483
1,22.1,Alopecia,1,17009483
2,22.1,Hair texture abnormal,3,17009483
3,22.1,Hair colour changes,3,17009483
4,22.1,Madarosis,3,17009483
0,22.1,Madarosis,3,17009484
1,22.1,Alopecia,3,17009484
2,22.1,Hair disorder,3,17009484
0,22.1,Neoplasm progression,6,17009485
1,22.1,Mental status changes,6,17009485
2,22.1,Rash,6,17009485
0,22.1,Neutropenic sepsis,5,17009488
0,22.1,Alopecia,3,17009522
1,22.1,Hair texture abnormal,3,17009522
2,22.1,Hair colour changes,3,17009522
3,22.1,Anxiety,6,17009522
4,22.1,Madarosis,3,17009522
5,22.1,Hair disorder,3,17009522
6,22.1,Depression,6,17009522
0,22.1,Neoplasm progression,6,17009532
1,22.1,Spondylitis,6,17009532
2,22.1,Back pain,3,17009532
0,22.1,Neoplasm progression,6,17009535
0,22.1,Lung infiltration,6,17009538
0,22.1,Hair colour changes,3,17009552
1,22.1,Hair texture abnormal,3,17009552
2,22.1,Madarosis,3,17009552
3,22.1,Hair disorder,3,17009552
4,22.1,Alopecia,3,17009552
0,22.1,Anal injury,6,17009567
1,22.1,Ageusia,6,17009567
2,22.1,Dysuria,6,17009567
3,22.1,Dyspepsia,6,17009567
4,22.1,Dry skin,3,17009567
5,22.1,Product residue present,6,17009567
6,22.1,Skin injury,3,17009567
7,22.1,Nausea,6,17009567
8,22.1,Dyschezia,6,17009567
9,22.1,Malaise,6,17009567
10,22.1,Depression,6,17009567
11,22.1,Gastritis,6,17009567
0,22.1,Neoplasm progression,6,17009620
1,22.1,Neuropathy peripheral,6,17009620
0,22.1,Cardiac arrest,2,17009632
1,22.1,Haemorrhage,6,17009632
0,22.1,Device leakage,,17009647
1,22.1,Intercepted product administration error,,17009647
2,22.1,Syringe issue,,17009647
3,22.1,Wrong technique in product usage process,,17009647
0,22.1,Death,5,17009661
0,22.1,Neutropenia,6,17009668
1,22.1,Anaemia,6,17009668
2,22.1,Thrombocytopenia,6,17009668
0,22.1,Blood creatine phosphokinase increased,3,17009680
0,22.1,Spinal cord compression,2,17009686
1,22.1,Urinary tract infection enterococcal,1,17009686
2,22.1,Sciatica,2,17009686
3,22.1,Small intestinal obstruction,1,17009686
4,22.1,Metastasis,2,17009686
5,22.1,Abdominal pain upper,2,17009686
6,22.1,Gastrooesophageal reflux disease,6,17009686
0,22.1,Movement disorder,3,17009704
1,22.1,Fatigue,3,17009704
2,22.1,Feeling abnormal,3,17009704
3,22.1,Pain,3,17009704
4,22.1,Back pain,3,17009704
0,22.1,Device occlusion,6,17009723
1,22.1,Infection,6,17009723
2,22.1,Neoplasm progression,6,17009723
0,22.1,Haemorrhoids,6,17009742
0,22.1,Oesophagitis,1,17009762
0,22.1,Nausea,3,17009789
1,22.1,Taste disorder,3,17009789
2,22.1,Eructation,3,17009789
3,22.1,Neoplasm progression,3,17009789
4,22.1,Flatulence,3,17009789
5,22.1,Hypertension,3,17009789
0,22.1,Toxicity to various agents,6,17009791
1,22.1,Neoplasm progression,6,17009791
0,22.1,Neoplasm progression,6,17009792
1,22.1,Toxicity to various agents,6,17009792
0,22.1,Neoplasm progression,3,17009802
1,22.1,Peripheral swelling,3,17009802
0,22.1,Epistaxis,6,17009809
1,22.1,Neutropenia,6,17009809
2,22.1,Rectal haemorrhage,6,17009809
3,22.1,Neoplasm progression,6,17009809
0,22.1,Rectal haemorrhage,6,17009813
0,22.1,Death,5,17009843
0,22.1,Loss of consciousness,1,17009846
0,22.1,Cytopenia,1,17009862
0,22.1,Malignant neoplasm progression,6,17009865
0,22.1,Toxicity to various agents,1,17009905
1,22.1,Mucosal inflammation,1,17009905
2,22.1,Fatigue,1,17009905
0,22.1,Neoplasm progression,6,17009906
1,22.1,Pancytopenia,6,17009906
0,22.1,Neoplasm progression,5,17009907
0,22.1,Fatigue,6,17009924
1,22.1,Diarrhoea,6,17009924
0,22.1,Haemorrhage,6,17009934
1,22.1,Peripheral sensory neuropathy,6,17009934
2,22.1,Proteinuria,6,17009934
3,22.1,Nausea,6,17009934
4,22.1,Epistaxis,6,17009934
5,22.1,Paraesthesia,6,17009934
0,22.1,Drug ineffective,6,17009937
0,22.1,Thrombocytopenia,3,17009948
1,22.1,Blood lactate dehydrogenase increased,3,17009948
2,22.1,Abdominal pain upper,3,17009948
3,22.1,Constipation,3,17009948
4,22.1,Hypersensitivity,1,17009948
5,22.1,C-reactive protein increased,3,17009948
6,22.1,Liver function test increased,3,17009948
7,22.1,Pyrexia,1,17009948
8,22.1,General physical health deterioration,3,17009948
9,22.1,Neutropenia,1,17009948
10,22.1,Blood bilirubin increased,3,17009948
0,22.1,Alopecia,3,17009972
1,22.1,Madarosis,3,17009972
2,22.1,Hair colour changes,3,17009972
3,22.1,Hair disorder,3,17009972
4,22.1,Hair texture abnormal,3,17009972
0,22.1,Fatigue,6,17009976
0,22.1,Fatigue,6,17009983
1,22.1,Dizziness,6,17009983
2,22.1,Dyspnoea,6,17009983
3,22.1,Cognitive disorder,6,17009983
4,22.1,Asthenia,6,17009983
5,22.1,Malaise,6,17009983
0,22.1,Diarrhoea,6,17009986
1,22.1,Pain in extremity,6,17009986
2,22.1,Alopecia,6,17009986
0,22.1,Fatigue,6,17009987
1,22.1,Abdominal pain upper,6,17009987
2,22.1,Hypersomnia,6,17009987
0,22.1,Throat irritation,6,17009993
1,22.1,Dyspepsia,1,17009993
2,22.1,Gingival swelling,6,17009993
0,22.1,Aortic aneurysm,2,17009997
0,22.1,Madarosis,3,17009999
1,22.1,Hair disorder,3,17009999
2,22.1,Alopecia,3,17009999
3,22.1,Hair texture abnormal,3,17009999
4,22.1,Hair colour changes,3,17009999
0,22.1,Dementia,6,17010006
1,22.1,Platelet count decreased,6,17010006
0,22.1,Infusion related reaction,1,17010037
1,22.1,Dyspnoea,1,17010037
2,22.1,Livedo reticularis,1,17010037
3,22.1,Chills,1,17010037
0,22.1,Left ventricular dysfunction,3,17010044
0,22.1,Death,5,17010049
0,22.1,Intra-abdominal haemorrhage,5,17010120
1,22.1,Decreased appetite,6,17010120
2,22.1,Hyperthyroidism,6,17010120
0,22.1,White blood cell count abnormal,6,17010172
0,22.1,White blood cell count decreased,2,17010179
0,22.1,Neoplasm progression,6,17010183
1,22.1,Neutropenia,6,17010183
0,22.1,Blood pressure increased,6,17010190
0,22.1,Blood count abnormal,1,17010215
1,22.1,Nausea,3,17010215
2,22.1,Asthenia,6,17010215
3,22.1,Sepsis,6,17010215
4,22.1,Campylobacter gastroenteritis,6,17010215
5,22.1,Hypersomnia,3,17010215
6,22.1,Hypernatraemia,6,17010215
7,22.1,Malaise,3,17010215
8,22.1,Loss of personal independence in daily activities,6,17010215
9,22.1,Influenza,6,17010215
10,22.1,Pneumonia,6,17010215
11,22.1,Vomiting,1,17010215
12,22.1,Epistaxis,6,17010215
13,22.1,Fatigue,2,17010215
14,22.1,Sleep disorder,6,17010215
15,22.1,Abdominal pain upper,2,17010215
0,22.1,Cardiac disorder,,17010226
1,22.1,Abdominal discomfort,,17010226
0,22.1,Hypophagia,,17010238
1,22.1,Treatment noncompliance,,17010238
0,22.1,Metastases to liver,6,17010252
1,22.1,Metastases to perineum,6,17010252
2,22.1,Ill-defined disorder,6,17010252
3,22.1,Neuropathy peripheral,6,17010252
4,22.1,Metastases to lymph nodes,6,17010252
5,22.1,Emotional disorder,6,17010252
6,22.1,Malignant neoplasm progression,6,17010252
0,22.1,Death,,17010259
0,22.1,Intentional product use issue,1,17010270
1,22.1,Fatigue,6,17010270
2,22.1,Product size issue,1,17010270
3,22.1,Dysphagia,1,17010270
0,22.1,Eye infection staphylococcal,1,17010336
1,22.1,Sepsis,1,17010336
2,22.1,Pneumonia,1,17010336
3,22.1,Febrile neutropenia,1,17010336
0,22.1,Dyspnoea,,17010346
1,22.1,Sleep disorder,,17010346
2,22.1,Restless legs syndrome,,17010346
3,22.1,Spinal compression fracture,,17010346
4,22.1,Amnesia,,17010346
5,22.1,Hot flush,,17010346
6,22.1,Fall,,17010346
7,22.1,Seizure,,17010346
0,22.1,Cardiac aneurysm repair,,17010355
1,22.1,Heart valve replacement,,17010355
0,22.1,Urticaria,1,17010368
1,22.1,Immune-mediated adverse reaction,5,17010368
0,22.1,Vertigo,1,17010369
0,22.1,Aspiration,5,17010374
0,22.1,Death,5,17010377
1,22.1,Weight decreased,6,17010377
2,22.1,Drug ineffective,6,17010377
0,22.1,Myelodysplastic syndrome,3,17010389
0,22.1,Malignant neoplasm progression,6,17010390
0,22.1,Malignant neoplasm progression,5,17010399
1,22.1,Metastases to central nervous system,5,17010399
0,22.1,Death,5,17010451
0,22.1,Pemphigoid,1,17010452
0,22.1,Metastases to adrenals,6,17010453
1,22.1,Malignant neoplasm progression,6,17010453
2,22.1,Electrocardiogram QT prolonged,6,17010453
0,22.1,Disease progression,3,17010465
1,22.1,Influenza,1,17010465
0,22.1,Hypogammaglobulinaemia,1,17010475
1,22.1,Opsoclonus myoclonus,1,17010475
2,22.1,West Nile viral infection,1,17010475
0,22.1,Malignant neoplasm progression,6,17010502
1,22.1,Cardiomyopathy,6,17010502
0,22.1,Diarrhoea,2,17010503
1,22.1,Drug resistance,6,17010503
2,22.1,Gene mutation,6,17010503
3,22.1,Malignant neoplasm progression,6,17010503
4,22.1,Neoplasm progression,6,17010503
0,22.1,Malignant neoplasm progression,6,17010511
0,22.1,Febrile neutropenia,1,17010538
1,22.1,Pneumonia,1,17010538
0,22.1,Jugular vein thrombosis,2,17010544
1,22.1,Cerebral venous sinus thrombosis,2,17010544
0,22.1,Anaphylactic reaction,1,17010545
0,22.1,Death,5,17010570
0,22.1,Death,5,17010580
0,22.1,Interstitial lung disease,6,17010624
1,22.1,Pneumonia,6,17010624
0,22.1,Alopecia,2,17010632
0,22.1,Blood pressure immeasurable,1,17010640
1,22.1,Flushing,2,17010640
2,22.1,Dizziness,2,17010640
3,22.1,Vomiting,2,17010640
4,22.1,Nausea,2,17010640
5,22.1,Pallor,2,17010640
6,22.1,Cold sweat,2,17010640
7,22.1,Heart rate increased,2,17010640
8,22.1,Pruritus,2,17010640
0,22.1,Psychological trauma,6,17010642
1,22.1,Alopecia,3,17010642
0,22.1,Alopecia,2,17010656
1,22.1,Psychological trauma,6,17010656
0,22.1,Alopecia,2,17010665
1,22.1,Impaired quality of life,6,17010665
2,22.1,Anxiety,6,17010665
3,22.1,Pain,6,17010665
4,22.1,Emotional distress,6,17010665
0,22.1,Alopecia,2,17010679
0,22.1,Incorrect dose administered,6,17010721
1,22.1,Renal failure,6,17010721
0,22.1,Pyrexia,6,17010728
1,22.1,Dermatitis exfoliative generalised,6,17010728
0,22.1,Groin pain,3,17010760
1,22.1,Death,5,17010760
2,22.1,Off label use,6,17010760
0,22.1,Disease progression,,17010794
0,22.1,Psychological trauma,6,17010820
1,22.1,Alopecia,3,17010820
0,22.1,Alopecia,2,17010824
1,22.1,Pain,6,17010824
2,22.1,Anxiety,6,17010824
3,22.1,Emotional distress,6,17010824
4,22.1,Psychological trauma,6,17010824
5,22.1,Impaired quality of life,6,17010824
0,22.1,Disease progression,6,17010844
1,22.1,Drug ineffective,6,17010844
0,22.1,Death,5,17010857
0,22.1,Hypersensitivity,6,17010859
1,22.1,Treatment failure,6,17010859
2,22.1,Platelet count decreased,6,17010859
0,22.1,Asthenopia,3,17010860
1,22.1,Aspartate aminotransferase increased,3,17010860
2,22.1,Blood alkaline phosphatase increased,3,17010860
3,22.1,Epistaxis,3,17010860
4,22.1,Flushing,3,17010860
5,22.1,Infusion related reaction,3,17010860
6,22.1,Nasopharyngitis,3,17010860
7,22.1,Peripheral swelling,3,17010860
8,22.1,Alanine aminotransferase increased,3,17010860
9,22.1,Fatigue,3,17010860
10,22.1,Gamma-glutamyltransferase increased,3,17010860
11,22.1,Pneumonia,3,17010860
12,22.1,Nausea,3,17010860
13,22.1,Hepatic enzyme increased,3,17010860
14,22.1,Rash,3,17010860
15,22.1,Blood lactate dehydrogenase increased,3,17010860
16,22.1,Blood pressure increased,3,17010860
17,22.1,Hypersensitivity,3,17010860
18,22.1,Pulmonary oedema,3,17010860
19,22.1,Ejection fraction,3,17010860
20,22.1,Ill-defined disorder,3,17010860
0,22.1,Malignant neoplasm progression,6,17010891
1,22.1,Drug resistance,6,17010891
2,22.1,Metastases to central nervous system,6,17010891
0,22.1,Malignant neoplasm progression,6,17010912
1,22.1,Death,5,17010912
0,22.1,Dermatitis acneiform,3,17010919
1,22.1,Hyponatraemia,3,17010919
0,22.1,Drug resistance,5,17010979
1,22.1,Malignant neoplasm progression,6,17010979
0,22.1,Sinusitis,3,17010983
1,22.1,Upper respiratory tract infection,6,17010983
0,22.1,Haematotoxicity,6,17010984
0,22.1,Platelet count decreased,6,17010993
1,22.1,Lymph node calcification,6,17010993
2,22.1,Cataract operation,6,17010993
3,22.1,Disease progression,6,17010993
0,22.1,Encephalitis autoimmune,1,17011002
1,22.1,Pyrexia,1,17011002
0,22.1,Drug ineffective,6,17011020
1,22.1,Disease progression,6,17011020
2,22.1,Recurrent cancer,6,17011020
0,22.1,Toxicity to various agents,6,17011021
1,22.1,Adverse drug reaction,6,17011021
2,22.1,Intentional product misuse,6,17011021
3,22.1,Drug intolerance,6,17011021
4,22.1,Recurrent cancer,6,17011021
0,22.1,Disease progression,6,17011022
1,22.1,Recurrent cancer,6,17011022
2,22.1,Intentional product misuse,6,17011022
3,22.1,Drug ineffective,6,17011022
0,22.1,Recurrent cancer,6,17011023
1,22.1,Disease progression,6,17011023
0,22.1,Recurrent cancer,6,17011024
1,22.1,Thrombocytopenia,6,17011024
2,22.1,Pancytopenia,6,17011024
0,22.1,Drug ineffective,6,17011025
1,22.1,Disease progression,6,17011025
2,22.1,Recurrent cancer,6,17011025
3,22.1,Drug intolerance,6,17011025
0,22.1,Disease progression,5,17011027
1,22.1,Regurgitation,6,17011027
2,22.1,Hospitalisation,6,17011027
0,22.1,Ileus,6,17011067
0,22.1,Peripheral swelling,3,17011118
1,22.1,Neoplasm progression,3,17011118
2,22.1,Pain,3,17011118
0,22.1,Neutropenic sepsis,5,17011160
0,22.1,Expired product administered,1,17011184
0,22.1,Acquired gene mutation,6,17011376
1,22.1,Drug resistance,6,17011376
2,22.1,Metastasis,5,17011376
3,22.1,Malignant neoplasm progression,6,17011376
0,22.1,Tumour haemorrhage,1,17011455
0,22.1,Parkinson^s disease,6,17011471
0,22.1,Malignant neoplasm progression,6,17011553
1,22.1,Aspartate aminotransferase increased,1,17011553
2,22.1,Alanine aminotransferase increased,1,17011553
3,22.1,Gamma-glutamyltransferase increased,3,17011553
4,22.1,Diarrhoea,6,17011553
0,22.1,Bone marrow failure,6,17011555
1,22.1,Hypomagnesaemia,1,17011555
2,22.1,Bundle branch block right,1,17011555
3,22.1,Loss of consciousness,1,17011555
0,22.1,Pulmonary embolism,6,17011567
0,22.1,Metastases to lymph nodes,6,17011571
0,22.1,Tumour marker increased,6,17011573
0,22.1,Gastrointestinal haemorrhage,2,17011576
1,22.1,Tumour haemorrhage,2,17011576
0,22.1,Diarrhoea,6,17011624
1,22.1,Lethargy,6,17011624
0,22.1,Dyspnoea,4,17011649
1,22.1,Pneumonitis,4,17011649
2,22.1,Mobility decreased,4,17011649
0,22.1,Off label use,6,17011656
1,22.1,Death,5,17011656
2,22.1,Prescribed underdose,6,17011656
0,22.1,Interstitial lung disease,2,17011657
0,22.1,Speech disorder,3,17011664
1,22.1,Underdose,6,17011664
2,22.1,Decreased appetite,3,17011664
3,22.1,Nausea,6,17011664
4,22.1,Full blood count decreased,1,17011664
5,22.1,Loss of personal independence in daily activities,6,17011664
6,22.1,Depression,3,17011664
7,22.1,Stomatitis,2,17011664
8,22.1,Constipation,6,17011664
9,22.1,Blood pressure increased,3,17011664
10,22.1,Atrial fibrillation,3,17011664
11,22.1,Oral mucosal blistering,2,17011664
12,22.1,Cough,2,17011664
13,22.1,Fatigue,3,17011664
14,22.1,Dysphonia,6,17011664
15,22.1,Anxiety,3,17011664
16,22.1,Weight decreased,3,17011664
0,22.1,Tumour lysis syndrome,6,17011681
1,22.1,Blood phosphorus increased,6,17011681
0,22.1,Breast cancer metastatic,6,17011693
1,22.1,Malignant neoplasm progression,6,17011693
2,22.1,Pleural effusion,6,17011693
3,22.1,Metastases to liver,6,17011693
4,22.1,Dyspnoea,6,17011693
5,22.1,Polyneuropathy,6,17011693
0,22.1,Taste disorder,3,17011696
1,22.1,Fatigue,3,17011696
2,22.1,Alopecia,1,17011696
3,22.1,Malignant pleural effusion,1,17011696
4,22.1,Decreased appetite,3,17011696
5,22.1,Hypertension,3,17011696
6,22.1,Hypokalaemia,1,17011696
7,22.1,Nasal dryness,1,17011696
8,22.1,Nasopharyngitis,1,17011696
9,22.1,Peripheral sensory neuropathy,1,17011696
10,22.1,Diarrhoea,1,17011696
11,22.1,Myalgia,3,17011696
12,22.1,Abdominal hernia,1,17011696
13,22.1,Pulmonary oedema,1,17011696
14,22.1,Sinusitis,3,17011696
15,22.1,Muscle spasms,3,17011696
16,22.1,Respiratory failure,1,17011696
0,22.1,Death,5,17011710
0,22.1,Interstitial lung disease,2,17011712
0,22.1,Heart rate increased,1,17011714
1,22.1,Hypoxia,1,17011714
2,22.1,Swelling of eyelid,1,17011714
3,22.1,Erythema,1,17011714
4,22.1,Hyperhidrosis,1,17011714
0,22.1,Product physical consistency issue,,17011719
1,22.1,Intercepted product preparation error,,17011719
2,22.1,Syringe issue,,17011719
3,22.1,Wrong technique in product usage process,,17011719
0,22.1,Intervertebral disc protrusion,4,17011721
0,22.1,Bone marrow failure,5,17011802
0,22.1,Radiation pneumonitis,1,17011807
1,22.1,Recall phenomenon,1,17011807
0,22.1,Pemphigoid,1,17011821
0,22.1,Gastrointestinal disorder,6,17011846
1,22.1,Neutrophil count decreased,6,17011846
2,22.1,White blood cell count decreased,6,17011846
0,22.1,Hair disorder,3,17011860
1,22.1,Hair colour changes,3,17011860
2,22.1,Hair texture abnormal,3,17011860
3,22.1,Alopecia,3,17011860
0,22.1,Hair texture abnormal,3,17011861
1,22.1,Alopecia,3,17011861
2,22.1,Madarosis,3,17011861
3,22.1,Hair colour changes,3,17011861
0,22.1,Neutropenia,6,17011870
1,22.1,Osteopenia,6,17011870
0,22.1,Hepatic function abnormal,3,17011871
0,22.1,Metastasis,6,17011889
1,22.1,Lung neoplasm malignant,6,17011889
0,22.1,Gastric cancer,6,17011892
0,22.1,Malignant neoplasm progression,6,17011922
0,22.1,Bradypnoea,5,17011931
1,22.1,Device programming error,5,17011931
2,22.1,Coma,5,17011931
0,22.1,Transaminases increased,1,17011937
1,22.1,Condition aggravated,3,17011937
2,22.1,Gamma-glutamyltransferase increased,3,17011937
0,22.1,Disease progression,5,17011940
1,22.1,Drug ineffective,6,17011940
0,22.1,Bronchial carcinoma,3,17012262
0,22.1,Neoplasm progression,6,17012263
1,22.1,Neuropathy peripheral,6,17012263
0,22.1,Renal failure,6,17012296
0,22.1,Product supply issue,6,17012300
1,22.1,Wrong technique in product usage process,6,17012300
2,22.1,Product quality issue,6,17012300
3,22.1,Drug ineffective,6,17012300
0,22.1,Adverse reaction,6,17012315
0,22.1,Hyponatraemia,2,17012350
1,22.1,Dermatitis acneiform,2,17012350
0,22.1,Fall,6,17012400
1,22.1,Feeling of body temperature change,6,17012400
2,22.1,Fatigue,3,17012400
3,22.1,Device occlusion,6,17012400
4,22.1,Failure to thrive,6,17012400
5,22.1,Microcytic anaemia,2,17012400
6,22.1,Back pain,6,17012400
7,22.1,Hyponatraemia,2,17012400
8,22.1,Delirium,3,17012400
9,22.1,Hypovolaemia,6,17012400
10,22.1,Bile duct obstruction,6,17012400
11,22.1,Hyperbilirubinaemia,6,17012400
0,22.1,Malignant neoplasm progression,5,17012403
1,22.1,Paralysis recurrent laryngeal nerve,5,17012403
2,22.1,Interstitial lung disease,2,17012403
0,22.1,Death,5,17012452
0,22.1,Paronychia,6,17012470
1,22.1,Diarrhoea,6,17012470
2,22.1,Hypertension,6,17012470
0,22.1,Vomiting,1,17012477
1,22.1,Febrile neutropenia,1,17012477
2,22.1,Vomiting,5,17012477
3,22.1,Diarrhoea,5,17012477
4,22.1,Thrombocytopenia,1,17012477
5,22.1,Haematemesis,1,17012477
0,22.1,Drug ineffective,6,17012479
0,22.1,Large intestinal haemorrhage,6,17012493
1,22.1,Malaise,6,17012493
2,22.1,Vomiting,6,17012493
3,22.1,Pain,6,17012493
4,22.1,Abdominal pain upper,1,17012493
0,22.1,Small intestinal obstruction,1,17012507
0,22.1,Death,5,17012511
0,22.1,Death,5,17012516
0,22.1,Death,5,17012521
0,22.1,Death,5,17012526
0,22.1,Pulmonary sepsis,1,17012528
0,22.1,Inflammation,1,17012548
1,22.1,Palpitations,3,17012548
2,22.1,Vomiting,1,17012548
3,22.1,Injection site discolouration,1,17012548
4,22.1,Anxiety,3,17012548
0,22.1,White blood cell count decreased,5,17012554
1,22.1,Haemoglobin decreased,5,17012554
0,22.1,Death,5,17012569
0,22.1,Intentional product use issue,6,17012609
1,22.1,Off label use,6,17012609
2,22.1,Metastases to liver,6,17012609
0,22.1,Bone marrow failure,2,17012655
0,22.1,Death,5,17012669
0,22.1,Neurotoxicity,6,17012690
0,22.1,Febrile neutropenia,5,17012803
1,22.1,Shock,5,17012803
0,22.1,Respiratory failure,5,17012810
0,22.1,Blood chloride decreased,3,17012817
1,22.1,Pruritus,3,17012817
2,22.1,Hypotension,3,17012817
3,22.1,Haemoglobin decreased,3,17012817
4,22.1,Panic attack,3,17012817
5,22.1,Rash,3,17012817
6,22.1,Confusional state,3,17012817
7,22.1,Erythema,3,17012817
8,22.1,Malaise,3,17012817
9,22.1,Platelet count increased,3,17012817
10,22.1,Fatigue,3,17012817
11,22.1,Heart rate increased,3,17012817
12,22.1,Hypothyroidism,3,17012817
13,22.1,Skin disorder,3,17012817
14,22.1,Haematocrit decreased,3,17012817
15,22.1,Malignant neoplasm progression,3,17012817
16,22.1,Mean cell haemoglobin concentration decreased,3,17012817
17,22.1,Blood test abnormal,3,17012817
18,22.1,Lymphocyte count decreased,3,17012817
0,22.1,Metastases to spine,6,17012838
1,22.1,Hot flush,6,17012838
2,22.1,Gait disturbance,6,17012838
3,22.1,Anxiety,6,17012838
4,22.1,Hormone level abnormal,6,17012838
5,22.1,Mobility decreased,6,17012838
6,22.1,Vomiting,6,17012838
7,22.1,Headache,6,17012838
8,22.1,Feeling abnormal,6,17012838
9,22.1,Metastases to bone,6,17012838
10,22.1,Contusion,6,17012838
11,22.1,Drug ineffective,6,17012838
12,22.1,Pain,6,17012838
13,22.1,Onychoclasis,6,17012838
14,22.1,Nausea,6,17012838
15,22.1,Metastases to pelvis,6,17012838
16,22.1,Metastases to ovary,6,17012838
17,22.1,Fatigue,6,17012838
18,22.1,Metastases to liver,1,17012838
19,22.1,Metastases to lung,2,17012838
20,22.1,Myalgia,6,17012838
21,22.1,Renal failure,6,17012838
22,22.1,Drug dependence,6,17012838
0,22.1,Body temperature increased,6,17012840
1,22.1,Feeling cold,1,17012840
2,22.1,General physical health deterioration,1,17012840
3,22.1,Chills,1,17012840
4,22.1,Hypertension,1,17012840
0,22.1,Intentional product use issue,6,17012861
1,22.1,Death,5,17012861
0,22.1,Off label use,6,17012877
1,22.1,Carcinoembryonic antigen increased,6,17012877
0,22.1,Pneumothorax,6,17012885
0,22.1,Hepatic failure,5,17012898
0,22.1,Erythema,1,17012916
1,22.1,Chest discomfort,1,17012916
2,22.1,Hypersensitivity,1,17012916
3,22.1,Hypersensitivity,1,17012916
4,22.1,Dyspnoea,1,17012916
5,22.1,Hot flush,1,17012916
0,22.1,Malignant neoplasm progression,5,17012931
1,22.1,Intentional product use issue,6,17012931
2,22.1,Gastrointestinal haemorrhage,5,17012931
0,22.1,Death,5,17012940
1,22.1,Intentional product use issue,6,17012940
2,22.1,Hospitalisation,6,17012940
0,22.1,Death,5,17012944
1,22.1,Intentional product use issue,6,17012944
0,22.1,Death,5,17012945
0,22.1,Malignant neoplasm progression,5,17012946
1,22.1,Intentional product use issue,6,17012946
0,22.1,Proteinuria,2,17013020
0,22.1,Decreased appetite,2,17013030
0,22.1,Breast cancer recurrent,6,17013204
1,22.1,Seizure,6,17013204
2,22.1,Headache,6,17013204
3,22.1,Vertigo,6,17013204
0,22.1,Blood creatinine increased,6,17013205
1,22.1,Blood albumin decreased,6,17013205
0,22.1,Arteriosclerosis coronary artery,6,17013329
1,22.1,Pneumonitis,6,17013329
2,22.1,Cystic lung disease,6,17013329
3,22.1,Bronchiectasis,6,17013329
4,22.1,Aortic arteriosclerosis,6,17013329
0,22.1,Metastases to liver,6,17013491
1,22.1,Abdominal pain upper,6,17013491
0,22.1,Neuropathy peripheral,6,17013544
1,22.1,Product use in unapproved indication,6,17013544
0,22.1,Bone pain,3,17013552
1,22.1,Vision blurred,3,17013552
2,22.1,Photopsia,3,17013552
3,22.1,Dizziness,3,17013552
4,22.1,Wrong technique in product usage process,3,17013552
5,22.1,Dysphagia,3,17013552
0,22.1,Ileus,3,17013555
1,22.1,Bone marrow failure,2,17013555
0,22.1,Atrioventricular block,6,17013586
0,22.1,Inappropriate schedule of product administration,6,17013588
1,22.1,Death,5,17013588
2,22.1,Product use in unapproved indication,6,17013588
0,22.1,Dizziness,3,17013691
1,22.1,Vision blurred,3,17013691
2,22.1,Disorientation,3,17013691
3,22.1,Head discomfort,3,17013691
4,22.1,Fatigue,3,17013691
0,22.1,Pericardial effusion,6,17013706
0,22.1,Hepatic encephalopathy,6,17013766
0,22.1,Malaise,6,17013782
0,22.1,Oedema,3,17013809
1,22.1,Death,5,17013809
0,22.1,Incontinence,6,17013869
1,22.1,Confusional state,3,17013869
2,22.1,Dementia,6,17013869
0,22.1,Malignant neoplasm progression,6,17013902
1,22.1,Non-small cell lung cancer metastatic,6,17013902
0,22.1,Respiratory disorder,5,17014028
0,22.1,Dermatitis acneiform,2,17014037
1,22.1,Colon cancer,5,17014037
2,22.1,Disease progression,5,17014037
3,22.1,Malaise,3,17014037
0,22.1,Intestinal obstruction,6,17014048
0,22.1,Vomiting,6,17014053
1,22.1,Mucosal inflammation,6,17014053
2,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,17014053
3,22.1,Alopecia,6,17014053
4,22.1,Haematotoxicity,6,17014053
5,22.1,Nausea,6,17014053
6,22.1,Diarrhoea,6,17014053
0,22.1,Drug reaction with eosinophilia and systemic symptoms,2,17014107
0,22.1,Malaise,6,17014190
1,22.1,Fatigue,6,17014190
2,22.1,Pyrexia,6,17014190
3,22.1,Intentional product use issue,6,17014190
0,22.1,Acute coronary syndrome,4,17014210
1,22.1,Hyperhidrosis,1,17014210
2,22.1,Vomiting,1,17014210
3,22.1,Malaise,1,17014210
0,22.1,Toxic skin eruption,1,17014240
1,22.1,Rash macular,1,17014240
2,22.1,Rash,1,17014240
0,22.1,Toxic skin eruption,1,17014241
0,22.1,Mucosal inflammation,2,17014358
1,22.1,Malignant neoplasm progression,3,17014358
2,22.1,Hypokalaemia,1,17014358
3,22.1,Pain in extremity,2,17014358
4,22.1,Diarrhoea,6,17014358
5,22.1,Xerosis,1,17014358
6,22.1,Asthenia,1,17014358
7,22.1,Weight decreased,2,17014358
8,22.1,General physical health deterioration,1,17014358
0,22.1,Decubitus ulcer,3,17014368
0,22.1,Transient ischaemic attack,1,17014372
1,22.1,Carotid artery stenosis,6,17014372
2,22.1,Myoclonic epilepsy,6,17014372
3,22.1,Seizure,6,17014372
4,22.1,Encephalitis,3,17014372
5,22.1,Altered state of consciousness,6,17014372
6,22.1,Internal carotid artery deformity,6,17014372
0,22.1,Ataxia,2,17014373
1,22.1,Memory impairment,2,17014373
2,22.1,Dyskinesia,2,17014373
3,22.1,Visual impairment,2,17014373
4,22.1,Drug interaction,6,17014373
5,22.1,Confusional state,2,17014373
6,22.1,Headache,2,17014373
7,22.1,Photophobia,2,17014373
8,22.1,Chorea,2,17014373
0,22.1,Interstitial lung disease,6,17014406
1,22.1,Pneumonia,6,17014406
0,22.1,Colon cancer,6,17014453
1,22.1,Anaemia,3,17014453
2,22.1,Malignant pleural effusion,1,17014453
3,22.1,Breast cancer,6,17014453
4,22.1,Renal failure,6,17014453
5,22.1,Asthenia,1,17014453
6,22.1,Malignant neoplasm progression,5,17014453
0,22.1,Drug interaction,6,17014454
1,22.1,Dyskinesia,2,17014454
2,22.1,Visual impairment,2,17014454
3,22.1,Ataxia,2,17014454
4,22.1,Photophobia,2,17014454
5,22.1,Confusional state,2,17014454
6,22.1,Toxicity to various agents,2,17014454
7,22.1,Memory impairment,2,17014454
8,22.1,Headache,2,17014454
0,22.1,Confusional state,2,17014473
1,22.1,Aphasia,2,17014473
0,22.1,Malignant neoplasm progression,5,17014524
0,22.1,Thrombocytopenia,1,17014579
0,22.1,Herpes zoster,1,17014704
0,22.1,Neutropenia,2,17014772
1,22.1,Hyperkalaemia,2,17014772
2,22.1,Haemoglobin decreased,2,17014772
3,22.1,Platelet count decreased,6,17014772
0,22.1,Hepatic failure,5,17014789
0,22.1,Death,5,17014796
0,22.1,Product dose omission,6,17014807
1,22.1,Fatigue,6,17014807
2,22.1,Central venous catheter removal,6,17014807
3,22.1,Dyspnoea,6,17014807
4,22.1,Flushing,6,17014807
5,22.1,Malaise,6,17014807
6,22.1,Heart rate increased,6,17014807
7,22.1,Headache,6,17014807
8,22.1,Vomiting,6,17014807
9,22.1,Dizziness,3,17014807
10,22.1,Migraine,6,17014807
11,22.1,Motion sickness,3,17014807
12,22.1,Nausea,3,17014807
0,22.1,Myalgia,6,17014826
1,22.1,Headache,6,17014826
2,22.1,Constipation,6,17014826
3,22.1,Recurrent cancer,6,17014826
0,22.1,Brain neoplasm,6,17014834
1,22.1,Metastases to central nervous system,6,17014834
0,22.1,Recurrent cancer,6,17014889
1,22.1,Pancytopenia,6,17014889
2,22.1,Thrombocytopenia,6,17014889
0,22.1,Dermatitis bullous,2,17014906
0,22.1,Ascites,6,17014997
1,22.1,Chronic obstructive pulmonary disease,6,17014997
2,22.1,Lung disorder,6,17014997
0,22.1,Cellulitis,3,17015029
0,22.1,Bone marrow failure,1,17015095
0,22.1,Metastases to central nervous system,6,17015111
0,22.1,Fluid retention,6,17015147
1,22.1,Dyspnoea,6,17015147
0,22.1,Somnolence,6,17015157
1,22.1,Fatigue,6,17015157
2,22.1,Neutropenia,6,17015157
3,22.1,Leukaemia,6,17015157
0,22.1,Diabetic ketoacidosis,6,17015164
1,22.1,Atrial fibrillation,6,17015164
2,22.1,Type 2 diabetes mellitus,3,17015164
3,22.1,Neutropenic sepsis,6,17015164
4,22.1,Glycosylated haemoglobin increased,6,17015164
0,22.1,Dysphonia,3,17015176
0,22.1,Cardiac failure,2,17015179
1,22.1,Dyspnoea,2,17015179
2,22.1,Cardiac dysfunction,3,17015179
0,22.1,Hypertension,6,17015181
1,22.1,Neurotoxicity,6,17015181
2,22.1,Anaemia,6,17015181
0,22.1,Burning sensation,3,17015215
1,22.1,Neutropenia,3,17015215
2,22.1,Mouth ulceration,6,17015215
3,22.1,Hypertension,3,17015215
4,22.1,Joint swelling,6,17015215
5,22.1,Vision blurred,3,17015215
6,22.1,Blood magnesium abnormal,3,17015215
7,22.1,Loss of personal independence in daily activities,6,17015215
8,22.1,Fatigue,3,17015215
9,22.1,Diarrhoea,1,17015215
10,22.1,Aphthous ulcer,3,17015215
11,22.1,Dry skin,3,17015215
12,22.1,Muscle spasms,3,17015215
13,22.1,Visual impairment,3,17015215
14,22.1,Dysgeusia,3,17015215
15,22.1,Weight decreased,3,17015215
16,22.1,Oedema peripheral,3,17015215
17,22.1,Balance disorder,3,17015215
18,22.1,Anaemia,3,17015215
19,22.1,Nausea,1,17015215
20,22.1,Vomiting,1,17015215
21,22.1,Decreased appetite,3,17015215
0,22.1,Deep vein thrombosis,6,17015224
1,22.1,Arteriosclerosis coronary artery,5,17015224
2,22.1,Myocardial ischaemia,5,17015224
3,22.1,Cardiac hypertrophy,5,17015224
4,22.1,Anal cancer,6,17015224
5,22.1,Off label use,6,17015224
0,22.1,Myalgia,1,17015239
1,22.1,Gait disturbance,1,17015239
